QuintilesIMS Reports Fourth-Quarter And Full-Year 2016 Results, Issues First-Quarter And Full-Year 2017 Guidance Post author:Sam Post published:February 13, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like 3 Depressed Biotechs that Investors with a Long-Term Perspective Should Buy Right Now April 11, 2016 <b>Janpix</b> Launches With $22 Million and Will be Helmed by Ex-Boehringer Ingelheim Exec October 10, 2017 Kyn Therapeutics Banks $49M to Advance Cancer Immunometabolism Therapies December 13, 2017
<b>Janpix</b> Launches With $22 Million and Will be Helmed by Ex-Boehringer Ingelheim Exec October 10, 2017